These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
692 related articles for article (PubMed ID: 3335302)
41. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology. Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766 [TBL] [Abstract][Full Text] [Related]
42. High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Waxman I; Raju GS; Critchlow J; Antonioli DA; Spechler SJ Am J Gastroenterol; 2006 Aug; 101(8):1773-9. PubMed ID: 16780561 [TBL] [Abstract][Full Text] [Related]
43. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106 [TBL] [Abstract][Full Text] [Related]
44. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Belghazi K; Bergman JJGHM; Pouw RE Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767 [TBL] [Abstract][Full Text] [Related]
45. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database. Nachiappan A; Ragunath K; Card T; Kaye P Scand J Gastroenterol; 2020 Jan; 55(1):9-13. PubMed ID: 31880176 [No Abstract] [Full Text] [Related]
46. Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot. Pilonis ND; Killcoyne S; Tan WK; O'Donovan M; Malhotra S; Tripathi M; Miremadi A; Debiram-Beecham I; Evans T; Phillips R; Morris DL; Vickery C; Harrison J; di Pietro M; Ortiz-Fernandez-Sordo J; Haidry R; Kerridge A; Sasieni PD; Fitzgerald RC Lancet Oncol; 2022 Feb; 23(2):270-278. PubMed ID: 35030332 [TBL] [Abstract][Full Text] [Related]
47. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Kariv R; Plesec TP; Goldblum JR; Bronner M; Oldenburgh M; Rice TW; Falk GW Clin Gastroenterol Hepatol; 2009 Jun; 7(6):653-8; quiz 606. PubMed ID: 19264576 [TBL] [Abstract][Full Text] [Related]
48. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. Peters JH; Clark GW; Ireland AP; Chandrasoma P; Smyrk TC; DeMeester TR J Thorac Cardiovasc Surg; 1994 Nov; 108(5):813-21; discussion 821-2. PubMed ID: 7967662 [TBL] [Abstract][Full Text] [Related]
49. A guide for surveillance of patients with Barrett's esophagus. Provenzale D; Kemp JA; Arora S; Wong JB Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136 [TBL] [Abstract][Full Text] [Related]
51. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus. Asthana N; Mandich D; Ligato S Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240 [TBL] [Abstract][Full Text] [Related]
52. Endoscopic features of buried Barrett's mucosa. Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645 [TBL] [Abstract][Full Text] [Related]
53. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Weston AP; Krmpotich PT; Cherian R; Dixon A; Topalosvki M Am J Gastroenterol; 1997 Mar; 92(3):407-13. PubMed ID: 9068459 [TBL] [Abstract][Full Text] [Related]
54. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma]. Incarbone R; Bonavina L; Bassi F; Peracchia A Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454 [TBL] [Abstract][Full Text] [Related]
55. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Canto MI; Setrakian S; Willis JE; Chak A; Petras RE; Sivak MV Endoscopy; 2001 May; 33(5):391-400. PubMed ID: 11396755 [TBL] [Abstract][Full Text] [Related]
56. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135 [TBL] [Abstract][Full Text] [Related]
57. Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Wong T; Tian J; Nagar AB Am J Med; 2010 May; 123(5):462-7. PubMed ID: 20399324 [TBL] [Abstract][Full Text] [Related]
58. The modern management of Barrett's oesophagus and related neoplasia: role of pathology. Kumarasinghe MP; Armstrong M; Foo J; Raftopoulos SC Histopathology; 2021 Jan; 78(1):18-38. PubMed ID: 33382493 [TBL] [Abstract][Full Text] [Related]
59. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. Lerut T; Coosemans W; Van Raemdonck D; Dillemans B; De Leyn P; Marnette JM; Geboes K J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1059-65; discussion 1065-6. PubMed ID: 8159027 [TBL] [Abstract][Full Text] [Related]
60. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma. Cotton CC; Eluri S; Shaheen NJ Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]